Medication info
Linadipo Tablets 5mg (Linagliptin)

Linadipo Tablets 5mg (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Red, round, film-coated tablet with convex faces and sharp edges.
Packaging
30 tablets (10 tablets / PTP X 3)
Approval status
Active

MFDS item code 201901817 · Approved 2019.03.26 · Insurance code 670609230

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this drug is 5 mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control problems in patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to effectively control blood sugar in patients with type 2 diabetes. It is administered together with dietary and exercise therapy, and it can be used alone or in combination with other medications to enhance therapeutic effects. This helps improve blood sugar control, aiding in diabetes management.

Dosage and Administration

Adult dosage

The recommended dose of this drug is 5 mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Precautions

This medication should not be taken by individuals allergic to the active ingredient or other components. It is also safe not to use in patients with type 1 diabetes or diabetic ketoacidosis. There may be an increased risk of hypoglycemia in patients taking insulin or sulfonylurea medications that can induce hypoglycemia, so dosage adjustments may be necessary. Patients with heart failure should use this drug cautiously, and if symptoms of acute pancreatitis arise, treatment should be discontinued immediately and a doctor consulted. Additionally, if symptoms resembling bullous pemphigoid occur on the skin, this medication should be discontinued and a specialist consulted. Hypoglycemic symptoms may occur during treatment with this medication, so symptoms should be closely monitored and appropriate measures should be taken when necessary. Use of this medication is not recommended for pregnant or nursing women, and special caution is advised for pregnant women due to a lack of safety data. This medication is not recommended for children under 10 years old, and even for adolescents over 10, it should be administered cautiously based on a doctor's judgment. Elderly patients can be administered without special dosage adjustments, but patients with impaired renal or hepatic function can also use it without dosage adjustments. In cases of overdose, the unabsorbed medication should be removed from the gastrointestinal tract and symptoms monitored, and appropriate treatment should be administered if necessary. This medication should be kept out of reach of children, and care should be taken not to transfer it to other containers as this may compromise quality.

Side effects

Hypoglycemia, hypersensitivity, angioedema, urticaria, cough, pancreatitis, constipation, oral ulcer formation, rash, bullous pemphigoid, severe and disabling arthralgia, rhabdomyolysis, weight gain, elevated lipase, elevated amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, abdominal pain, enterocolitis, intestinal obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech impairment, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, headache, sensory abnormalities, postherpetic neuralgia, hemiparesis, syncope, drowsiness, chest discomfort, asthenia, epistaxis, oropharyngeal pain, speech disturbance, allergic rhinitis, exercise-induced dyspnea, wet cough, nasal discharge, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, urine positive for leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, elevated ALT, elevated AST, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eyes, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, fatty liver disease, hearing loss, erectile dysfunction, thyroid goiter, pruritus, hypertension, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Red, round, film-coated tablet with convex faces and sharp edges.

Package unit

30 tablets (10 tablets / PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.